P2RX1 and acute myeloid leukemia: In addition, P2X1-knockdown immunophenotypic human primary CD34+ AML-LICs grew much slower in vitro (Fig. 6E–G) and resulted in approximately 50% fewer colony counts or 40% fewer derived total AML cells than the control cells (Fig. 6H–J).